SAB BIOTHERAPEUTICS INC (SABS) Stock Cash Flow
NASDAQ:SABS - Nasdaq - US78397T2024 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.57M | -42.19M | -18.74M | -17.14M | 20.12M | |||
| Depreciation Amortization | 4.86M | 3.65M | 3.17M | 1.49M | 383.00K | |||
| Change In Working Capital | -842.04K | 2.33M | -238.00K | 11.68M | -11.95M | |||
| Interest Paid | 369.61K | 245.00K | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | N/A | N/A | N/A | |||
| Other non cash items | 3.34M | 11.10M | -7.65M | 5.96M | 1.46M | |||
| OPERATING CASH FLOW | -38.21M | -25.12M | -23.46M | 1.99M | 10.01M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -349.79K | -197.00K | -2.17M | -10.94M | -12.73M | |||
| Other Investing Activity | -21.01M | 44.00K | 76.00K | 0.00 | 9.00K | |||
| INVESTING CASH FLOW | -21.36M | -153.00K | -2.09M | -10.94M | -12.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -671.19K | -390.00K | -1.19M | 1.54M | -1.58M | |||
| Stock Issued/Repurchased | 67.18M | 67.16M | 2.24M | 34.35M | 10.56M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -80.00K | |||
| FINANCING CASH FLOW | 66.25M | 66.77M | 1.05M | 35.89M | 8.98M | |||
| Exchange Rate Effect | N/A | 18.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | 6.75M | 41.52M | -24.50M | 26.93M | 6.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -38.21M | -25.12M | -23.46M | 1.99M | 10.01M | |||
| Capital Expenditure | -349.79K | -197.00K | -2.17M | -10.94M | -12.73M | |||
| FREE CASH FLOW | -38.56M | -25.32M | -25.63M | -8.96M | -2.73M | |||
All data in USD